SAINT-CLOUD, France,
April 23, 2021 /PRNewswire/ --
Ethypharm announces today that it now has a fully established
affiliate to operate directly in Italy, the third largest pharmaceutical market
in Europe. Under the leadership of
Bruno Rago, Ethypharm Italy will
reinforce the group's commercial footprint in Europe, notably in its core therapeutic area
of the Central Nervous System.
Founded in 1977 in France,
Ethypharm is a specialty pharmaceutical company with solid roots in
Europe and China. After its establishment in the
United Kingdom and Germany in 2015, the addition of a direct
presence in Italy is a major
milestone to strengthen the group's commercial platform in
Europe. Ethypharm Italy Srl is
headquartered in Padova and will serve both the hospital and retail
pharmacy channels.
Ethypharm Italy does not start from scratch but builds on solid
foundations. Ethypharm already had several of its products
distributed in Italy, notably in
the Central Nervous System area. The team in place reflects the
human values of Ethypharm: entrepreneurial spirit, strong
pharmaceutical expertise and unique commitment to improve the life
of patients. "Bruno Rago is a
senior pharma and biotech industry executive. With him, Ethypharm
benefits from over 20 years of experience. Bruno has a passion for
building and establishing pharmaceutical affiliates in Italy and Europe. We know that under his leadership,
Ethypharm Italy has a bright future," says Jean Monin, Chief Commercial Operations Officer
of Ethypharm.
Italy is one of the world's
leading pharmaceutical markets. In 2019, the pharmaceutical market
in Italy was estimated at
30 billion euros[1].
Within it, the off-patent CNS market was worth 3,4 billlion euros.
"I am happy to take this new challenge and I am confident as I
already know the potential and the value of Ethypharm's strategy
and portfolio. I also know that we are able to relieve patients in
pathologies such as epilepsy, pain and depression where healthcare
professionnals and patients have needs," explains Bruno Rago, general manager of Ethypharm
Italy.
About Ethypharm
Ethypharm is a European pharmaceutical company focused on two
therapeutic areas: the Central Nervous System and Critical Care.
Ethypharm markets its drugs directly in Europe and China, and with partners in North America and the Middle East where its drugs are in high
demand. The Group employs more than 1,500 people, mainly in
Europe and China. Ethypharm works closely with
authorities and healthcare professionals to ensure the appropriate
use of and access to its medicines, by as many people as
possible.
For more information visit www.ethypharm.com and
follow us on LinkedIn
[1] https://www.statista.com/statistics/458845/european-pharmaceutical-markets-turnover
Media Contacts
Ethypharm: Mai Tran,
presse@ethypharm.com, + 33 (0)6 64 74 70 80
Logo -
https://mma.prnewswire.com/media/1222194/Ethypharm_Logo.jpg